- Home
- PTN vs NMTC Comparison
PTN vs NMTC Comparison
Compare PTN & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTN
- NMTC
- Stock Information
- Founded
- PTN 1986
- NMTC 2009
- Country
- PTN United States
- NMTC United States
- Employees
- PTN N/A
- NMTC N/A
- Industry
- PTN Biotechnology: Pharmaceutical Preparations
- NMTC Medical/Dental Instruments
- Sector
- PTN Health Care
- NMTC Health Care
- Exchange
- PTN Nasdaq
- NMTC Nasdaq
- Market Cap
- PTN 25.4M
- NMTC 21.0M
- IPO Year
- PTN 1993
- NMTC N/A
- Fundamental
- Price
- PTN $1.00
- NMTC $1.15
- Analyst Decision
- PTN Strong Buy
- NMTC
- Analyst Count
- PTN 1
- NMTC 0
- Target Price
- PTN $7.00
- NMTC N/A
- AVG Volume (30 Days)
- PTN 1.7M
- NMTC 250.2K
- Earning Date
- PTN 02-13-2025
- NMTC 02-12-2025
- Dividend Yield
- PTN N/A
- NMTC N/A
- EPS Growth
- PTN N/A
- NMTC N/A
- EPS
- PTN N/A
- NMTC N/A
- Revenue
- PTN $350,000.00
- NMTC $5,749,521.00
- Revenue This Year
- PTN N/A
- NMTC $292.88
- Revenue Next Year
- PTN N/A
- NMTC N/A
- P/E Ratio
- PTN N/A
- NMTC N/A
- Revenue Growth
- PTN N/A
- NMTC 104.21
- 52 Week Low
- PTN $0.68
- NMTC $0.55
- 52 Week High
- PTN $3.99
- NMTC $1.50
- Technical
- Relative Strength Index (RSI)
- PTN 50.51
- NMTC 55.15
- Support Level
- PTN $0.99
- NMTC $1.00
- Resistance Level
- PTN $1.08
- NMTC $1.25
- Average True Range (ATR)
- PTN 0.14
- NMTC 0.11
- MACD
- PTN 0.01
- NMTC -0.00
- Stochastic Oscillator
- PTN 35.59
- NMTC 64.66
About PTN Palatin Technologies Inc.
Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system. The product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with significant unmet medical need and commercial potential.
About NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.